Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]

Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] was reported 110194 times

Drugs of the Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 CSF HIV ESCAPE SYNDROME 118 0.8551
1 PINEALOBLASTOMA 76 0.8172
2 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA 105 0.8140
3 BONE DEMINERALISATION 846 0.7989
4 SKELETAL INJURY 7941 0.7671
5 BONE LOSS 10599 0.7043
6 HUMAN IMMUNODEFICIENCY VIRUS TRANSMISSION 195 0.7014
7 HIV VIRAEMIA 144 0.6857
8 BONE DENSITY DECREASED 20138 0.6421
9 ULTRASOUND ANTENATAL SCREEN 56 0.5833
10 MULTIPLE FRACTURES 9566 0.5817
11 HIV-ASSOCIATED NEUROCOGNITIVE DISORDER 64 0.5766
12 IMMUNE RECONSTITUTION SYNDROME 733 0.5678
13 VIRAL MUTATION IDENTIFIED 2065 0.5601
14 BLOOD HIV RNA INCREASED 946 0.5212
15 ACUTE HIV INFECTION 127 0.5142
16 TOOTH INJURY 2106 0.4846
17 VIROLOGIC FAILURE 2594 0.4819
18 TOOTH LOSS 9915 0.4778
19 PROTEIN TOTAL ABNORMAL 509 0.3909
20 LIPODYSTROPHY ACQUIRED 828 0.3896
21 MITOCHONDRIAL TOXICITY 316 0.3849
22 TOTAL LUNG CAPACITY INCREASED 104 0.3824
23 FANCONI SYNDROME ACQUIRED 661 0.3762
24 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS 126 0.3761
25 BONE DENSITY ABNORMAL 1286 0.3438
26 OSTEOPENIA 5109 0.3363
27 OSTEONECROSIS 10776 0.3278
28 RENAL INJURY 9017 0.3032
29 GENITALIA EXTERNAL AMBIGUOUS 52 0.3006
30 CAUDAL REGRESSION SYNDROME 46 0.2949
31 DANDY-WALKER SYNDROME 75 0.2896
32 OSTEOMALACIA 444 0.2872
33 ULTRASOUND ANTENATAL SCREEN ABNORMAL 62 0.2818
34 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 1387 0.2781
35 ANHEDONIA 7291 0.2772
36 BIRTH MARK 56 0.2692
37 MECONIUM STAIN 41 0.2662
38 HEPATITIS B DNA INCREASED 170 0.2522
39 GENOTYPE DRUG RESISTANCE TEST POSITIVE 255 0.2481
40 PATHOGEN RESISTANCE 2257 0.2474
41 KAPOSI'S SARCOMA 124 0.2470
42 CD4 LYMPHOCYTES INCREASED 55 0.2361
43 RENAL TUBULAR DYSFUNCTION 130 0.2301
44 VIRAL LOAD INCREASED 856 0.2203
45 OSTEOPOROSIS 9054 0.2199
46 FAT REDISTRIBUTION 50 0.2155
47 SYPHILIS 152 0.2091
48 MENINGOMYELOCELE 125 0.2083
49 HIV TEST POSITIVE 136 0.2057
50 POLYDACTYLY 238 0.2052
51 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 105 0.2008
52 TRISOMY 18 76 0.1995
53 CD4 LYMPHOCYTES DECREASED 421 0.1965
54 DEGENERATIVE BONE DISEASE 86 0.1941
55 MITOCHONDRIAL CYTOPATHY 84 0.1909
56 ACQUIRED IMMUNODEFICIENCY SYNDROME 97 0.1869
57 HIV INFECTION 551 0.1826
58 GLOMERULAR FILTRATION RATE ABNORMAL 258 0.1821
59 FANCONI SYNDROME 256 0.1809
60 ECONOMIC PROBLEM 2707 0.1784
61 CONGENITAL UMBILICAL HERNIA 63 0.1689
62 CHRONIC KIDNEY DISEASE 12670 0.1666
63 MACROCEPHALY 63 0.1624
64 FACIAL WASTING 43 0.1599
65 HYDROPS FOETALIS 96 0.1566
66 EXOMPHALOS 83 0.1546
67 TRISOMY 21 190 0.1508
68 LIPOATROPHY 142 0.1492
69 CONGENITAL HYDROCEPHALUS 75 0.1479
70 STILLBIRTH 698 0.1443
71 NEPHROPATHY 1334 0.1427
72 NEURAL TUBE DEFECT 101 0.1389
73 LIPOHYPERTROPHY 86 0.1383
74 VITAMIN D DEFICIENCY 1348 0.1381
75 HEPATITIS B REACTIVATION 438 0.1379
76 TEETH BRITTLE 144 0.1375
77 PLAGIOCEPHALY 66 0.1323
78 ACQUIRED GENE MUTATION 164 0.1251
79 UMBILICAL CORD ABNORMALITY 65 0.1233
80 ANAEMIA NEONATAL 59 0.1224
81 CUSHING'S SYNDROME 84 0.1209
82 VIRAEMIA 160 0.1154
83 ATRIOVENTRICULAR SEPTAL DEFECT 54 0.1149
84 CONGENITAL FOOT MALFORMATION 52 0.1145
85 MENINGITIS CRYPTOCOCCAL 195 0.1114
86 HEPATITIS B 662 0.1097
87 RENAL TUBULAR DISORDER 304 0.1080
88 FOETAL EXPOSURE DURING DELIVERY 73 0.1077
89 MENINGITIS TUBERCULOUS 60 0.1073
90 SUDDEN INFANT DEATH SYNDROME 52 0.1057
91 GLYCOSURIA 141 0.1043
92 MALARIA 72 0.1021
93 ANAL ATRESIA 54 0.1011
94 SKULL MALFORMATION 65 0.1011
95 CONGENITAL HYDRONEPHROSIS 71 0.0993
96 DRUG RESISTANCE 2532 0.0985
97 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 106 0.0980
98 PSYCHIATRIC DECOMPENSATION 191 0.0976
99 CEREBRAL TOXOPLASMOSIS 91 0.0974
100 PROTEIN TOTAL INCREASED 244 0.0916
101 NODULAR REGENERATIVE HYPERPLASIA 58 0.0903
102 ANENCEPHALY 49 0.0867
103 CYTOMEGALOVIRUS CHORIORETINITIS 168 0.0861
104 SPINA BIFIDA 179 0.0859
105 CENTRAL OBESITY 63 0.0853
106 FRACTURE 1611 0.0850
107 RENAL FAILURE 11187 0.0842
108 GLOMERULAR FILTRATION RATE INCREASED 69 0.0835
109 OSTEOPOROTIC FRACTURE 159 0.0830
110 GENE MUTATION 164 0.0828
111 MULTIPLE-DRUG RESISTANCE 248 0.0799
112 T-LYMPHOCYTE COUNT DECREASED 53 0.0777
113 INTRA-UTERINE DEATH 123 0.0766
114 PREMATURE RUPTURE OF MEMBRANES 184 0.0763
115 DEATH NEONATAL 105 0.0754
116 PRODUCT USE IN UNAPPROVED THERAPEUTIC ENVIRONMENT 65 0.0744
117 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 80 0.0727
118 CEREBRAL VENTRICLE DILATATION 83 0.0720
119 CRYPTORCHISM 79 0.0703
120 HEPATITIS A 59 0.0696
121 EMOTIONAL DISTRESS 8303 0.0685
122 FOETAL DEATH 354 0.0682
123 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 72 0.0678
124 HAND FRACTURE 475 0.0670
125 RENAL COLIC 151 0.0667
126 FOETAL GROWTH RETARDATION 52 0.0664
127 PLACENTAL DISORDER 62 0.0655
128 RETINAL TOXICITY 67 0.0650
129 DYSLIPIDAEMIA 322 0.0633
130 HYPERLACTACIDAEMIA 169 0.0630
131 SEPSIS NEONATAL 51 0.0628
132 CLEFT LIP AND PALATE 70 0.0626
133 VISCERAL LEISHMANIASIS 45 0.0623
134 TWIN PREGNANCY 52 0.0618
135 NEONATAL DISORDER 98 0.0618
136 ABORTION INDUCED 574 0.0609
137 PORTAL HYPERTENSION 187 0.0606
138 ARNOLD-CHIARI MALFORMATION 57 0.0597
139 ADRENAL SUPPRESSION 50 0.0593
140 POLYHYDRAMNIOS 60 0.0588
141 PYELOCALIECTASIS 56 0.0585
142 LIMB MALFORMATION 46 0.0583
143 FAT TISSUE INCREASED 83 0.0572
144 MYCOBACTERIUM AVIUM COMPLEX INFECTION 153 0.0569
145 PSYCHOMOTOR SKILLS IMPAIRED 149 0.0568
146 AMNIOTIC CAVITY INFECTION 41 0.0567
147 DRUG EXPOSURE DURING PREGNANCY 1921 0.0564
148 FOETAL EXPOSURE DURING PREGNANCY 4582 0.0563
149 PLACENTA PRAEVIA 44 0.0560
150 RENAL TUBULAR ACIDOSIS 121 0.0554
151 CRYPTOCOCCOSIS 90 0.0552
152 TOXOPLASMOSIS 59 0.0546
153 OPHTHALMOPLEGIA 86 0.0545
154 TOOTH FRACTURE 597 0.0541
155 FIBULA FRACTURE 153 0.0531
156 ANAEMIA MACROCYTIC 112 0.0524
157 FOOT FRACTURE 993 0.0523
158 LIVE BIRTH 434 0.0518
159 PULMONARY TUBERCULOSIS 220 0.0514
160 END STAGE RENAL DISEASE 925 0.0507
161 VANISHING BILE DUCT SYNDROME 56 0.0502
162 BLOOD AMYLASE INCREASED 86 0.0502
163 SMALL FOR DATES BABY 249 0.0501
164 VENTRICULAR SEPTAL DEFECT 285 0.0497
165 FOETAL GROWTH RESTRICTION 302 0.0496
166 HISTOPLASMOSIS 87 0.0491
167 HEPATOSPLENOMEGALY 124 0.0483
168 ANOGENITAL WARTS 43 0.0482
169 TEMPERATURE REGULATION DISORDER 106 0.0475
170 BLOOD LACTIC ACID INCREASED 247 0.0468
171 MATERNAL DRUGS AFFECTING FOETUS 358 0.0467
172 BLOOD CREATININE INCREASED 3034 0.0464
173 CYTOLYTIC HEPATITIS 152 0.0457
174 TIBIA FRACTURE 213 0.0454
175 PNEUMOCYSTIS JIROVECI PNEUMONIA 101 0.0453
176 DEPRESSIVE SYMPTOM 158 0.0448
177 JAUNDICE CHOLESTATIC 157 0.0444
178 PREMATURE BABY 1330 0.0441
179 PROTEINURIA 839 0.0441
180 HYPERTRIGLYCERIDAEMIA 258 0.0440
181 HEPATIC FIBROSIS 151 0.0440
182 LOW BIRTH WEIGHT BABY 348 0.0438
183 MICROCEPHALY 56 0.0436
184 MACROCYTOSIS 50 0.0431
185 DEPRESSION SUICIDAL 149 0.0430
186 FOETAL DISTRESS SYNDROME 91 0.0429
187 HYPOSPADIAS 89 0.0427
188 ANAL CANCER 41 0.0423
189 CAESAREAN SECTION 492 0.0422
190 ATYPICAL MYCOBACTERIAL INFECTION 59 0.0417
191 HYPOPHOSPHATAEMIA 307 0.0415
192 HYPOMANIA 152 0.0413
193 JAW FRACTURE 89 0.0412
194 RADIUS FRACTURE 97 0.0403
195 RENAL IMPAIRMENT 3393 0.0403
196 ANKLE FRACTURE 624 0.0403
197 CUSHINGOID 128 0.0398
198 BONE MARROW TOXICITY 47 0.0397
199 PREMATURE SEPARATION OF PLACENTA 61 0.0396
200 TALIPES 122 0.0392
201 PREMATURE LABOUR 222 0.0392
202 OESOPHAGEAL CANDIDIASIS 156 0.0391
203 WRIST FRACTURE 465 0.0388
204 MYCOBACTERIAL INFECTION 66 0.0383
205 PATENT DUCTUS ARTERIOSUS 151 0.0380
206 GLOMERULAR FILTRATION RATE DECREASED 456 0.0371
207 ABORTION SPONTANEOUS 1484 0.0370
208 PRE-ECLAMPSIA 175 0.0368
209 NEPHROPATHY TOXIC 413 0.0368
210 VARICES OESOPHAGEAL 111 0.0367
211 SPEECH DISORDER DEVELOPMENTAL 105 0.0366
212 CONGENITAL ANOMALY 279 0.0360
213 BONE DISORDER 655 0.0359
214 TEARFULNESS 154 0.0358
215 HYPERBILIRUBINAEMIA 364 0.0351
216 HEART DISEASE CONGENITAL 123 0.0347
217 EXPOSURE DURING BREAST FEEDING 115 0.0347
218 CALCULUS URINARY 53 0.0344
219 EXPOSURE DURING PREGNANCY 2108 0.0339
220 NON-HODGKIN'S LYMPHOMA 44 0.0336
221 GENITAL HERPES 51 0.0333
222 HEPATITIS FULMINANT 98 0.0330
223 CLAVICLE FRACTURE 125 0.0326
224 RENAL TUBULAR NECROSIS 317 0.0323
225 PROTEIN URINE PRESENT 161 0.0323
226 DYSMORPHISM 76 0.0322
227 ATRIAL SEPTAL DEFECT 270 0.0322
228 GASTROINTESTINAL TUBE INSERTION 80 0.0320
229 PREMATURE DELIVERY 510 0.0320
230 DISSEMINATED TUBERCULOSIS 82 0.0319
231 NORMAL NEWBORN 170 0.0312
232 CARDIAC MURMUR 269 0.0311
233 INTERVERTEBRAL DISC DEGENERATION 286 0.0309
234 OLIGOHYDRAMNIOS 102 0.0306
235 BLOOD CREATININE ABNORMAL 105 0.0303
236 STRONGYLOIDIASIS 49 0.0303
237 CACHEXIA 156 0.0303
238 BLOOD PHOSPHORUS DECREASED 110 0.0301
239 OESOPHAGEAL VARICES HAEMORRHAGE 65 0.0299
240 RIB FRACTURE 610 0.0296
241 GESTATIONAL DIABETES 141 0.0296
242 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 242 0.0293
243 LYMPHADENITIS 71 0.0293
244 OPPORTUNISTIC INFECTION 54 0.0292
245 PATHOLOGICAL FRACTURE 148 0.0291
246 ANXIETY 8292 0.0291
247 NEONATAL RESPIRATORY DISTRESS SYNDROME 103 0.0291
248 HEPATITIS C 347 0.0287
249 SHOULDER FRACTURE 47 0.0287
250 HEPATOMEGALY 277 0.0282
251 OCULAR ICTERUS 121 0.0279
252 VOLVULUS 66 0.0278
253 RHINITIS ALLERGIC 122 0.0274
254 BLOOD CREATINE INCREASED 121 0.0273
255 ECTOPIC PREGNANCY 83 0.0270
256 HYPERPARATHYROIDISM SECONDARY 67 0.0267
257 PREGNANCY 534 0.0266
258 EYELID PTOSIS 265 0.0261
259 QUALITY OF LIFE DECREASED 349 0.0260
260 SPINAL COMPRESSION FRACTURE 214 0.0259
261 PORTAL VEIN THROMBOSIS 83 0.0257
262 HEPATOTOXICITY 566 0.0254
263 LIPIDS INCREASED 51 0.0252
264 PSYCHOMOTOR RETARDATION 71 0.0252
265 SARCOIDOSIS 120 0.0252
266 HEPATITIS CHOLESTATIC 152 0.0252
267 HYPERPARATHYROIDISM 52 0.0252
268 DECREASED ACTIVITY 272 0.0252
269 HYDROCEPHALUS 134 0.0246
270 HEPATITIS TOXIC 63 0.0242
271 JAUNDICE 634 0.0235
272 HYPERPHOSPHATAEMIA 50 0.0232
273 TREATMENT NONCOMPLIANCE 1270 0.0232
274 SPINAL OSTEOARTHRITIS 203 0.0231
275 HEPATIC NECROSIS 86 0.0228
276 NASAL POLYPS 112 0.0227
277 BLOOD BILIRUBIN INCREASED 614 0.0227
278 DRUG INTERACTION 3546 0.0223
279 PATELLA FRACTURE 52 0.0223
280 CLEFT PALATE 43 0.0222
281 FACIAL BONES FRACTURE 80 0.0222
282 HUMERUS FRACTURE 106 0.0220
283 UNDERWEIGHT 43 0.0218
284 STRABISMUS 64 0.0218
285 ACUTE KIDNEY INJURY 3307 0.0216
286 MATERNAL EXPOSURE DURING PREGNANCY 1859 0.0208
287 HIP ARTHROPLASTY 318 0.0207
288 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 67 0.0206
289 CEREBELLAR SYNDROME 45 0.0205
290 SCHIZOPHRENIA 249 0.0205
291 VENTRICULAR HYPERTROPHY 51 0.0203
292 RENAL CYST 161 0.0203
293 HEPATIC ENCEPHALOPATHY 188 0.0201
294 PARADOXICAL DRUG REACTION 73 0.0198
295 HYPERLIPIDAEMIA 237 0.0198
296 FAECES PALE 44 0.0198
297 SPINAL STENOSIS 81 0.0196
298 SPLENOMEGALY 228 0.0194
299 ACUTE LYMPHOCYTIC LEUKAEMIA 55 0.0194
300 BILIRUBIN CONJUGATED INCREASED 45 0.0192
301 CREATININE RENAL CLEARANCE DECREASED 77 0.0192
302 HEPATITIS 482 0.0188
303 UPPER LIMB FRACTURE 371 0.0186
304 DENTAL CARIES 204 0.0184
305 BRAIN HERNIATION 55 0.0184
306 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 884 0.0184
307 HYPERURICAEMIA 75 0.0182
308 FEMORAL NECK FRACTURE 92 0.0179
309 HYDRONEPHROSIS 134 0.0179
310 FIBROSIS 55 0.0179
311 BRONCHIECTASIS 119 0.0176
312 LIVER TRANSPLANT 64 0.0176
313 HEPATIC FAILURE 530 0.0176
314 ORAL CANDIDIASIS 231 0.0175
315 LOWER LIMB FRACTURE 337 0.0175
316 RENAL TRANSPLANT 63 0.0174
317 OSTEOARTHRITIS 726 0.0171
318 LIPASE INCREASED 131 0.0171
319 LACTIC ACIDOSIS 548 0.0169
320 AUTOIMMUNE HEPATITIS 117 0.0168
321 PNEUMOCYSTIS JIROVECII PNEUMONIA 168 0.0167
322 TREATMENT FAILURE 1377 0.0166
323 HEPATIC CIRRHOSIS 308 0.0164
324 RENAL FAILURE ACUTE 693 0.0163
325 CONGESTIVE CARDIOMYOPATHY 68 0.0163
326 ALANINE AMINOTRANSFERASE INCREASED 999 0.0163
327 ENCEPHALITIS 112 0.0162
328 ENDOTRACHEAL INTUBATION 45 0.0160
329 DRUG SCREEN FALSE POSITIVE 44 0.0159
330 HISTIOCYTOSIS HAEMATOPHAGIC 47 0.0158
331 STRESS FRACTURE 85 0.0157
332 CHOLESTASIS 300 0.0156
333 NEPHROLITHIASIS 713 0.0155
334 TRANSAMINASES INCREASED 345 0.0155
335 APLASIA PURE RED CELL 53 0.0154
336 DRUG-INDUCED LIVER INJURY 481 0.0153
337 ASPARTATE AMINOTRANSFERASE INCREASED 812 0.0153
338 COMPRESSION FRACTURE 81 0.0151
339 PAIN 9205 0.0150
340 STEVENS-JOHNSON SYNDROME 333 0.0150
341 PSYCHOTIC DISORDER 437 0.0148
342 GRANULOMA 51 0.0147
343 LYMPHADENOPATHY 521 0.0147
344 RENAL PAIN 156 0.0147
345 SPINAL FRACTURE 294 0.0147
346 ADRENAL INSUFFICIENCY 177 0.0146
347 HIP FRACTURE 469 0.0146
348 FOOD ALLERGY 112 0.0145
349 GAMMA-GLUTAMYLTRANSFERASE INCREASED 321 0.0145
350 BLOOD CREATINE PHOSPHOKINASE INCREASED 412 0.0143
351 HEPATITIS ACUTE 93 0.0143
352 HAEMOLYTIC ANAEMIA 128 0.0143
353 BLOOD TRIGLYCERIDES INCREASED 252 0.0142
354 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 47 0.0142
355 LUMBAR VERTEBRAL FRACTURE 65 0.0142
356 HEPATOCELLULAR INJURY 201 0.0142
357 BACTERIAL SEPSIS 46 0.0141
358 DEVELOPMENTAL DELAY 126 0.0140
359 ACUTE HEPATIC FAILURE 190 0.0139
360 TESTICULAR PAIN 44 0.0139
361 BLOOD ALKALINE PHOSPHATASE INCREASED 340 0.0137
362 NEPHROGENIC ANAEMIA 63 0.0136
363 DERMATITIS EXFOLIATIVE 68 0.0136
364 EXPOSURE VIA BREAST MILK 53 0.0133
365 EXERCISE TOLERANCE DECREASED 75 0.0130
366 HEPATOCELLULAR CARCINOMA 99 0.0130
367 BENIGN PROSTATIC HYPERPLASIA 67 0.0130
368 MYOPATHY 112 0.0130
369 RASH MACULO-PAPULAR 287 0.0129
370 ATTENTION DEFICIT HYPERACTIVITY DISORDER 54 0.0128
371 RENAL DISORDER 594 0.0127
372 HYPERCHOLESTEROLAEMIA 123 0.0127
373 ACIDOSIS 97 0.0127
374 GASTROENTERITIS 182 0.0125
375 HEPATIC STEATOSIS 232 0.0124
376 DEPRESSION 2823 0.0124
377 NEPHROTIC SYNDROME 85 0.0124
378 PARANOIA 212 0.0123
379 PRODUCT DISPENSING ERROR 267 0.0122
380 LUNG NEOPLASM 52 0.0122
381 METABOLIC ACIDOSIS 389 0.0122
382 NEUROLOGICAL SYMPTOM 69 0.0121
383 LYMPHOMA 186 0.0120
384 INTENTIONAL DOSE OMISSION 342 0.0120
385 MENINGITIS 80 0.0120
386 HERPES VIRUS INFECTION 69 0.0120
387 DRUG LEVEL INCREASED 197 0.0119
388 CERVICAL VERTEBRAL FRACTURE 41 0.0119
389 PANCYTOPENIA 661 0.0118
390 CHOLELITHIASIS 385 0.0117
391 ASCITES 340 0.0116
392 UMBILICAL HERNIA 54 0.0115
393 ANAEMIA 2194 0.0115
394 RENAL FUNCTION TEST ABNORMAL 53 0.0114
395 POLYDIPSIA 45 0.0114
396 CYTOMEGALOVIRUS INFECTION 189 0.0114
397 ATAXIA 134 0.0113
398 BLOOD LACTATE DEHYDROGENASE INCREASED 177 0.0112
399 MALABSORPTION 58 0.0111
400 METABOLIC DISORDER 64 0.0110
401 INTRACRANIAL PRESSURE INCREASED 61 0.0109
402 HEPATIC ENZYME INCREASED 744 0.0109
403 PRODUCT DOSE OMISSION IN ERROR 309 0.0109
404 COELIAC DISEASE 106 0.0108
405 PULSELESS ELECTRICAL ACTIVITY 45 0.0108
406 NECROSIS 59 0.0106
407 PANCREATITIS ACUTE 238 0.0106
408 TUBULOINTERSTITIAL NEPHRITIS 197 0.0105
409 PRESCRIBED OVERDOSE 203 0.0105
410 CANDIDIASIS 42 0.0105
411 LOW DENSITY LIPOPROTEIN INCREASED 81 0.0105
412 HERPES SIMPLEX 68 0.0105
413 TOXIC SKIN ERUPTION 105 0.0104
414 HYPOTONIA 104 0.0104
415 ABNORMAL DREAMS 287 0.0104
416 IMMUNODEFICIENCY 154 0.0103
417 LIVER FUNCTION TEST ABNORMAL 296 0.0102
418 HYPERTONIA 58 0.0101
419 DYSSTASIA 295 0.0101
420 BURSITIS 122 0.0100
421 POST-TRAUMATIC STRESS DISORDER 67 0.0100
422 TRANSPLANT REJECTION 80 0.0100
423 DRUG TOXICITY 136 0.0100
424 TOXIC EPIDERMAL NECROLYSIS 151 0.0099
425 POLYNEUROPATHY 119 0.0099
426 ANOREXIA 128 0.0099
427 DIPLOPIA 256 0.0098
428 BLOOD ALBUMIN DECREASED 78 0.0098
429 STAPHYLOCOCCAL SEPSIS 48 0.0097
430 HEPATIC FUNCTION ABNORMAL 361 0.0097
431 DISSEMINATED INTRAVASCULAR COAGULATION 136 0.0097
432 MAJOR DEPRESSION 70 0.0096
433 BLOOD URIC ACID INCREASED 55 0.0095
434 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 71 0.0095
435 RHABDOMYOLYSIS 393 0.0094
436 TOOTH EXTRACTION 116 0.0093
437 NEUROTOXICITY 163 0.0093
438 MALNUTRITION 104 0.0093
439 NERVOUS SYSTEM DISORDER 289 0.0093
440 PYELONEPHRITIS 80 0.0092
441 HEPATIC CYTOLYSIS 116 0.0091
442 FAILURE TO THRIVE 47 0.0090
443 MYOSITIS 81 0.0090
444 APLASTIC ANAEMIA 47 0.0090
445 CEREBRAL ISCHAEMIA 46 0.0089
446 POLYURIA 73 0.0089
447 HYPOALBUMINAEMIA 69 0.0089
448 CHOLANGITIS 55 0.0089
449 FEMUR FRACTURE 274 0.0088
450 TACHYPNOEA 120 0.0088
451 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 77 0.0087
452 MULTI-ORGAN FAILURE 150 0.0087
453 TORSADE DE POINTES 68 0.0087
454 EOSINOPHILIA 151 0.0086
455 HAEMODIALYSIS 72 0.0086
456 HYPOVOLAEMIC SHOCK 41 0.0086
457 ENTEROCOCCAL INFECTION 41 0.0085
458 LIVER DISORDER 376 0.0085
459 PELVIC FRACTURE 66 0.0085
460 BONE MARROW FAILURE 172 0.0085
461 LEUKOPENIA 422 0.0084
462 PSYCHIATRIC SYMPTOM 62 0.0084
463 BONE PAIN 490 0.0084
464 COAGULOPATHY 138 0.0083
465 PANCREATITIS 431 0.0081
466 FACE OEDEMA 137 0.0081
467 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 209 0.0081
468 ACUTE MYOCARDIAL INFARCTION 239 0.0081
469 PNEUMONIA BACTERIAL 74 0.0081
470 DRUG LEVEL DECREASED 82 0.0080
471 LIVER INJURY 197 0.0080
472 NIGHTMARE 277 0.0080
473 MUSCLE ATROPHY 101 0.0080
474 GLUCOSE TOLERANCE IMPAIRED 47 0.0079
475 CHROMATURIA 179 0.0079
476 RASH GENERALISED 202 0.0078
477 PRODUCT DOSE OMISSION ISSUE 2276 0.0077
478 THROMBOCYTOPENIA 863 0.0077
479 LYMPHOPENIA 109 0.0077
480 PURPURA 67 0.0076
481 HAEMATURIA 259 0.0076
482 ODYNOPHAGIA 45 0.0075
483 IMPAIRED WORK ABILITY 160 0.0075
484 DRUG SCREEN POSITIVE 59 0.0075
485 LEFT VENTRICULAR DYSFUNCTION 50 0.0075
486 ERECTILE DYSFUNCTION 191 0.0074
487 DRUG LEVEL BELOW THERAPEUTIC 41 0.0074
488 RENAL FAILURE CHRONIC 57 0.0074
489 RESPIRATORY DISTRESS 204 0.0074
490 HAEMOLYSIS 57 0.0074
491 DRUG ERUPTION 130 0.0073
492 DERMATITIS ALLERGIC 92 0.0073
493 EPSTEIN-BARR VIRUS INFECTION 45 0.0072
494 CLOSTRIDIUM DIFFICILE COLITIS 76 0.0072
495 CENTRAL NERVOUS SYSTEM LESION 98 0.0071
496 LUNG INFILTRATION 63 0.0071
497 HYPERKALAEMIA 248 0.0071
498 NEUTROPENIA 958 0.0070
499 DERMATITIS BULLOUS 51 0.0070
500 HYPERTHYROIDISM 102 0.0070
501 EYELID OEDEMA 81 0.0070
502 ENCEPHALOPATHY 170 0.0069
503 NEUROPATHY PERIPHERAL 657 0.0069
504 DIFFUSE LARGE B-CELL LYMPHOMA 53 0.0069
505 ATRIOVENTRICULAR BLOCK COMPLETE 46 0.0069
506 INABILITY TO AFFORD MEDICATION 68 0.0068
507 SKIN HYPERPIGMENTATION 58 0.0067
508 STATUS EPILEPTICUS 76 0.0067
509 PYREXIA 2307 0.0067
510 CARDIOMEGALY 82 0.0067
511 SKIN LESION 182 0.0066
512 AGRANULOCYTOSIS 123 0.0066
513 HYPERTRANSAMINASAEMIA 46 0.0066
514 NEUTROPENIC SEPSIS 47 0.0066
515 SUICIDAL IDEATION 600 0.0065
516 HYPOKALAEMIA 302 0.0065
517 PRODUCT STORAGE ERROR 567 0.0065
518 PRODUCT USE COMPLAINT 102 0.0065
519 DYSPHAGIA 613 0.0065
520 BRAIN OEDEMA 80 0.0063
521 DIABETES MELLITUS 479 0.0063
522 SUDDEN DEATH 66 0.0062
523 CARDIOMYOPATHY 92 0.0062
524 INTERVERTEBRAL DISC PROTRUSION 135 0.0062
525 HEMIPLEGIA 51 0.0061
526 UVEITIS 83 0.0061
527 GASTRITIS 159 0.0060
528 ACUTE CORONARY SYNDROME 50 0.0060
529 TUMOUR LYSIS SYNDROME 53 0.0060
530 ANURIA 51 0.0059
531 DIALYSIS 83 0.0058
532 NIGHT SWEATS 187 0.0058
533 SEPTIC SHOCK 252 0.0058
534 MULTIPLE ORGAN DYSFUNCTION SYNDROME 164 0.0058
535 MENTAL DISORDER 251 0.0058
536 BOWEL MOVEMENT IRREGULARITY 44 0.0057
537 RESPIRATORY RATE INCREASED 51 0.0057
538 LIVER FUNCTION TEST INCREASED 123 0.0057
539 HEMIPARESIS 97 0.0057
540 ESCHERICHIA INFECTION 47 0.0057
541 POLLAKIURIA 238 0.0057
542 THERAPY CHANGE 56 0.0057
543 BRONCHOPULMONARY ASPERGILLOSIS 44 0.0057
544 IMMUNOSUPPRESSION 50 0.0057
545 MOBILITY DECREASED 405 0.0056
546 GRAND MAL CONVULSION 52 0.0056
547 VITAMIN D DECREASED 48 0.0056
548 SEPSIS 624 0.0056
549 PRODUCT DOSE OMISSION 364 0.0056
550 TRICUSPID VALVE INCOMPETENCE 44 0.0055
551 ARTERIOSCLEROSIS 52 0.0055
552 BLOOD UREA INCREASED 92 0.0055
553 VENTRICULAR EXTRASYSTOLES 57 0.0055
554 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 94 0.0055
555 RASH ERYTHEMATOUS 262 0.0055
556 ELECTROCARDIOGRAM QT PROLONGED 197 0.0055
557 HAEMATOTOXICITY 52 0.0055
558 BLOOD CHOLESTEROL INCREASED 254 0.0054
559 HYPERGLYCAEMIA 198 0.0054
560 MITRAL VALVE INCOMPETENCE 61 0.0054
561 ACUTE RESPIRATORY DISTRESS SYNDROME 95 0.0054
562 PALLOR 146 0.0054
563 PSEUDOMONAS INFECTION 46 0.0054
564 ERYTHEMA MULTIFORME 50 0.0054
565 APPENDICITIS 49 0.0052
566 DEPRESSED MOOD 277 0.0052
567 GASTROINTESTINAL DISORDER 468 0.0052
568 RHINITIS 42 0.0052
569 HYPERCALCAEMIA 63 0.0051
570 ELECTROLYTE IMBALANCE 59 0.0051
571 GOUT 91 0.0051
572 BIPOLAR DISORDER 55 0.0051
573 PULMONARY HYPERTENSION 105 0.0050
574 NOCTURIA 61 0.0050
575 AFFECT LABILITY 48 0.0050
576 BLOOD SODIUM DECREASED 94 0.0050
577 ABDOMINAL DISTENSION 518 0.0050
578 MYALGIA 840 0.0049
579 GENERALISED OEDEMA 61 0.0049
580 INTENTIONAL PRODUCT USE ISSUE 431 0.0049
581 HAEMARTHROSIS 44 0.0049
582 TENDONITIS 76 0.0049
583 CHOLECYSTITIS 58 0.0049
584 SPINAL PAIN 57 0.0049
585 SLEEP DISORDER 343 0.0049
586 DISEASE RECURRENCE 231 0.0049
587 CONTRAINDICATED PRODUCT ADMINISTERED 147 0.0049
588 GAIT DISTURBANCE 929 0.0048
589 VOMITING 2267 0.0048
590 WEIGHT INCREASED 1078 0.0048
591 FACIAL PARALYSIS 41 0.0048
592 PERICARDIAL EFFUSION 111 0.0048
593 CONJUNCTIVITIS 89 0.0048
594 LOSS OF LIBIDO 43 0.0048
595 GENERAL PHYSICAL HEALTH DETERIORATION 553 0.0048
596 SUICIDE ATTEMPT 288 0.0047
597 RESPIRATORY FAILURE 345 0.0047
598 TOOTH DISORDER 105 0.0047
599 BLOOD CALCIUM DECREASED 53 0.0047
600 GYNAECOMASTIA 145 0.0047
601 PARALYSIS 67 0.0047
602 MUCOSAL INFLAMMATION 122 0.0047
603 MENTAL STATUS CHANGES 129 0.0046
604 VASCULITIS 54 0.0046
605 CANDIDA INFECTION 78 0.0046
606 PHARYNGITIS 57 0.0046
607 GENERALISED TONIC-CLONIC SEIZURE 76 0.0046
608 EATING DISORDER 97 0.0046
609 HYPONATRAEMIA 256 0.0045
610 HALLUCINATION, AUDITORY 72 0.0045
611 SINUS TACHYCARDIA 64 0.0045
612 INSOMNIA 1195 0.0045
613 HYPERTENSION 950 0.0045
614 STAPHYLOCOCCAL INFECTION 147 0.0045
615 GASTROOESOPHAGEAL REFLUX DISEASE 356 0.0044
616 PNEUMOTHORAX 70 0.0044
617 HELICOBACTER INFECTION 45 0.0044
618 MANIA 72 0.0044
619 OSTEOMYELITIS 79 0.0044
620 MYOCARDITIS 50 0.0044
621 TYPE 2 DIABETES MELLITUS 146 0.0043
622 WEIGHT DECREASED 1202 0.0043
623 BACTERAEMIA 51 0.0043
624 ASTHENIA 1613 0.0043
625 HAEMOGLOBIN DECREASED 438 0.0043
626 ABDOMINAL PAIN 991 0.0043
627 DRUG DISPENSING ERROR 65 0.0042
628 PRODUCT USE ISSUE 799 0.0042
629 NEURALGIA 103 0.0042
630 HAEMATEMESIS 107 0.0042
631 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 220 0.0042
632 RASH 1833 0.0042
633 FEAR 113 0.0042
634 MYOCLONUS 50 0.0042
635 THERAPY CESSATION 214 0.0042
636 DISTURBANCE IN ATTENTION 224 0.0041
637 RASH PAPULAR 93 0.0041
638 PLATELET COUNT INCREASED 54 0.0041
639 KIDNEY INFECTION 81 0.0041
640 OESOPHAGITIS 45 0.0041
641 DYSURIA 151 0.0041
642 CONDITION AGGRAVATED 1247 0.0041
643 PERIPHERAL COLDNESS 56 0.0041
644 FEBRILE NEUTROPENIA 270 0.0041
645 UPPER RESPIRATORY TRACT INFECTION 188 0.0041
646 HYPOXIA 141 0.0040
647 DIARRHOEA 2569 0.0040
648 JOINT INJURY 85 0.0040
649 OEDEMA 215 0.0040
650 BLOOD IRON DECREASED 47 0.0040
651 NERVE INJURY 44 0.0040
652 OEDEMA PERIPHERAL 482 0.0040
653 NO THERAPEUTIC RESPONSE 48 0.0039
654 BACK PAIN 913 0.0039
655 JOINT DISLOCATION 41 0.0039
656 ALTERED STATE OF CONSCIOUSNESS 84 0.0039
657 IMMUNE SYSTEM DISORDER 51 0.0039
658 EPILEPSY 118 0.0039
659 CONVULSION 219 0.0038
660 PHOTOSENSITIVITY REACTION 63 0.0038
661 BACTERIAL INFECTION 71 0.0038
662 UPPER GASTROINTESTINAL HAEMORRHAGE 64 0.0038
663 LABORATORY TEST ABNORMAL 112 0.0038
664 SKIN ULCER 98 0.0038
665 THERAPY NON-RESPONDER 170 0.0038
666 NAUSEA 2975 0.0038
667 DRUG INTOLERANCE 361 0.0037
668 MASS 52 0.0037
669 OBESITY 59 0.0037
670 MYOCARDIAL ISCHAEMIA 42 0.0037
671 MUSCULOSKELETAL DISORDER 70 0.0037
672 LETHARGY 211 0.0037
673 DYSARTHRIA 138 0.0037
674 PRURITUS GENERALISED 79 0.0036
675 CORONARY ARTERY DISEASE 110 0.0036
676 C-REACTIVE PROTEIN INCREASED 132 0.0036
677 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 122 0.0036
678 INSURANCE ISSUE 55 0.0036
679 HYPOCALCAEMIA 68 0.0036
680 ABSCESS 57 0.0036
681 BLOOD POTASSIUM INCREASED 58 0.0036
682 MOUTH ULCERATION 75 0.0036
683 DEAFNESS 93 0.0036
684 GASTRIC ULCER 67 0.0035
685 COORDINATION ABNORMAL 49 0.0035
686 VERTIGO 214 0.0035
687 DISORIENTATION 139 0.0035
688 HYPERSENSITIVITY 650 0.0035
689 APATHY 51 0.0035
690 DYSPNOEA EXERTIONAL 131 0.0035
691 RESTLESSNESS 127 0.0035
692 HYPOKINESIA 50 0.0034
693 TACHYCARDIA 305 0.0034
694 MUSCULOSKELETAL DISCOMFORT 59 0.0034
695 HERPES ZOSTER 196 0.0034
696 APHASIA 103 0.0034
697 MUSCULAR WEAKNESS 387 0.0034
698 VISUAL ACUITY REDUCED 113 0.0034
699 PNEUMONIA 1101 0.0034
700 CEREBRAL INFARCTION 83 0.0034
701 VENTRICULAR TACHYCARDIA 56 0.0034
702 ANGINA PECTORIS 97 0.0034
703 PULMONARY ARTERIAL HYPERTENSION 49 0.0034
704 ARTHRALGIA 1406 0.0034
705 PSYCHOMOTOR HYPERACTIVITY 56 0.0034
706 THIRST 60 0.0034
707 PANIC ATTACK 122 0.0033
708 CIRCULATORY COLLAPSE 57 0.0033
709 LUNG NEOPLASM MALIGNANT 137 0.0033
710 PULMONARY EMBOLISM 316 0.0033
711 POOR QUALITY SLEEP 71 0.0033
712 DEHYDRATION 438 0.0033
713 HAEMATOCRIT DECREASED 65 0.0033
714 ULCER 52 0.0033
715 BLOOD URINE PRESENT 62 0.0033
716 FATIGUE 2534 0.0033
717 FLATULENCE 184 0.0032
718 SENSORY DISTURBANCE 52 0.0032
719 RASH PRURITIC 175 0.0032
720 MOOD ALTERED 88 0.0032
721 TINNITUS 148 0.0032
722 COMA 153 0.0032
723 SKIN DISORDER 107 0.0032
724 GASTRIC DISORDER 110 0.0032
725 LEUKOCYTOSIS 58 0.0032
726 PLEURAL EFFUSION 195 0.0032
727 SCIATICA 51 0.0032
728 DELIRIUM 111 0.0032
729 CARDIOVASCULAR DISORDER 81 0.0032
730 NEUTROPHIL COUNT DECREASED 130 0.0032
731 ACUTE RESPIRATORY FAILURE 61 0.0032
732 ANGIOEDEMA 140 0.0032
733 DECREASED APPETITE 728 0.0031
734 DEEP VEIN THROMBOSIS 203 0.0031
735 CONFUSIONAL STATE 500 0.0031
736 PNEUMONIA ASPIRATION 77 0.0031
737 SEROTONIN SYNDROME 59 0.0031
738 PARAESTHESIA 482 0.0031
739 HEADACHE 1917 0.0031
740 SPEECH DISORDER 160 0.0031
741 GAIT INABILITY 102 0.0030
742 HYPOAESTHESIA 456 0.0030
743 SHOCK 70 0.0030
744 HYPERHIDROSIS 391 0.0030
745 INTENTIONAL PRODUCT MISUSE 265 0.0030
746 SWELLING FACE 197 0.0030
747 BRAIN FOG 47 0.0030
748 CORONARY ARTERY OCCLUSION 41 0.0030
749 HALLUCINATION 225 0.0030
750 ACCIDENTAL OVERDOSE 109 0.0030
751 PHOTOPHOBIA 56 0.0030
752 MELAENA 65 0.0030
753 HAEMOPTYSIS 82 0.0029
754 ADVERSE DRUG REACTION 263 0.0029
755 ABNORMAL BEHAVIOUR 116 0.0029
756 PLATELET COUNT DECREASED 312 0.0029
757 IRRITABILITY 176 0.0029
758 CYANOSIS 46 0.0029
759 AMNESIA 190 0.0029
760 DERMATITIS 61 0.0029
761 DEPRESSED LEVEL OF CONSCIOUSNESS 115 0.0029
762 CHILLS 340 0.0029
763 FLUID RETENTION 146 0.0029
764 HOSPITALISATION 440 0.0029
765 HYPOPHAGIA 73 0.0029
766 MYOCARDIAL INFARCTION 498 0.0029
767 TOXICITY TO VARIOUS AGENTS 481 0.0028
768 AGITATION 209 0.0028
769 RESPIRATORY TRACT INFECTION 74 0.0028
770 PULMONARY MASS 42 0.0028
771 LOCAL SWELLING 49 0.0028
772 CARDIAC ARREST 231 0.0028
773 ARTHRITIS 220 0.0028
774 DYSPEPSIA 275 0.0028
775 BODY TEMPERATURE INCREASED 57 0.0028
776 CEREBRAL HAEMORRHAGE 100 0.0028
777 ILL-DEFINED DISORDER 169 0.0028
778 LUNG DISORDER 136 0.0028
779 PALPITATIONS 325 0.0028
780 MENTAL IMPAIRMENT 67 0.0028
781 COGNITIVE DISORDER 129 0.0028
782 BLOOD POTASSIUM DECREASED 83 0.0028
783 ACUTE MYELOID LEUKAEMIA 43 0.0028
784 CARDIAC FAILURE 221 0.0028
785 INFECTION 398 0.0027
786 INFLAMMATION 141 0.0027
787 ABDOMINAL PAIN UPPER 561 0.0027
788 ABDOMINAL DISCOMFORT 457 0.0027
789 BLINDNESS 111 0.0027
790 ORAL HERPES 53 0.0027
791 MOVEMENT DISORDER 87 0.0027
792 THINKING ABNORMAL 50 0.0027
793 FAECES DISCOLOURED 58 0.0027
794 PAIN IN EXTREMITY 787 0.0027
795 HAEMORRHOIDS 52 0.0027
796 HYPOTHYROIDISM 85 0.0027
797 KNEE ARTHROPLASTY 56 0.0027
798 TOOTHACHE 48 0.0026
799 ISCHAEMIC STROKE 47 0.0026
800 RASH MACULAR 92 0.0026
801 INTERNATIONAL NORMALISED RATIO INCREASED 75 0.0026
802 OFF LABEL USE 2301 0.0026
803 DIABETIC KETOACIDOSIS 63 0.0026
804 CELLULITIS 132 0.0026
805 CHEST PAIN 485 0.0026
806 GLYCOSYLATED HAEMOGLOBIN INCREASED 66 0.0026
807 VIRAL INFECTION 87 0.0026
808 SKIN DISCOLOURATION 120 0.0026
809 SEIZURE 301 0.0026
810 RED BLOOD CELL COUNT DECREASED 74 0.0026
811 PRODUCT PHYSICAL ISSUE 52 0.0026
812 WHEEZING 151 0.0025
813 SOMNOLENCE 510 0.0025
814 HYPOGLYCAEMIA 122 0.0025
815 RETCHING 53 0.0025
816 DIZZINESS 1238 0.0025
817 DEATH 2122 0.0025
818 HALLUCINATION, VISUAL 52 0.0025
819 SLEEP APNOEA SYNDROME 47 0.0025
820 LOSS OF CONSCIOUSNESS 314 0.0024
821 ARRHYTHMIA 116 0.0024
822 DRUG DOSE OMISSION 404 0.0024
823 MOOD SWINGS 77 0.0024
824 ROAD TRAFFIC ACCIDENT 101 0.0024
825 MALAISE 1057 0.0024
826 AMENORRHOEA 42 0.0024
827 COUGH 671 0.0024
828 GLAUCOMA 46 0.0024
829 NEOPLASM PROGRESSION 83 0.0024
830 PRODUCT USE IN UNAPPROVED INDICATION 591 0.0024
831 OVERDOSE 513 0.0024
832 PERITONITIS 49 0.0024
833 MUSCULOSKELETAL PAIN 123 0.0023
834 HYPERSOMNIA 67 0.0023
835 SKIN EXFOLIATION 197 0.0023
836 JOINT STIFFNESS 61 0.0023
837 LIMB INJURY 63 0.0023
838 AGGRESSION 116 0.0023
839 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 417 0.0023
840 PRURITUS 887 0.0023
841 RESPIRATORY DISORDER 69 0.0023
842 BLISTER 129 0.0023
843 URINARY INCONTINENCE 68 0.0023
844 ASTHMA 259 0.0023
845 CRYING 83 0.0023
846 HYPOTENSION 458 0.0023
847 DISCOMFORT 139 0.0023
848 ANGER 77 0.0023
849 FEEDING DISORDER 46 0.0023
850 WHITE BLOOD CELL COUNT DECREASED 244 0.0022
851 PRODUCTIVE COUGH 107 0.0022
852 NECK PAIN 124 0.0022
853 MEDICATION ERROR 123 0.0022
854 HEART RATE IRREGULAR 50 0.0022
855 UNEVALUABLE EVENT 167 0.0022
856 INTENTIONAL OVERDOSE 141 0.0022
857 DYSKINESIA 89 0.0022
858 SYNCOPE 219 0.0022
859 ABDOMINAL PAIN LOWER 55 0.0022
860 ADVERSE EVENT 200 0.0022
861 EAR PAIN 42 0.0022
862 INJURY 151 0.0021
863 EYE DISORDER 70 0.0021
864 INFUSION RELATED REACTION 141 0.0021
865 CARDIO-RESPIRATORY ARREST 88 0.0021
866 PRESYNCOPE 51 0.0021
867 DYSPNOEA 1176 0.0021
868 EXTRA DOSE ADMINISTERED 84 0.0021
869 LIP SWELLING 69 0.0021
870 ABASIA 51 0.0021
871 MUSCULOSKELETAL STIFFNESS 180 0.0021
872 DRUG INEFFECTIVE 2706 0.0021
873 RECTAL HAEMORRHAGE 88 0.0020
874 JOINT SWELLING 247 0.0020
875 GASTROINTESTINAL HAEMORRHAGE 170 0.0020
876 ARTHROPATHY 113 0.0020
877 NEOPLASM MALIGNANT 135 0.0020
878 INFLUENZA LIKE ILLNESS 166 0.0020
879 CONSTIPATION 435 0.0020
880 INTESTINAL OBSTRUCTION 75 0.0020
881 MEMORY IMPAIRMENT 273 0.0020
882 FEELING COLD 55 0.0020
883 HAEMATOMA 51 0.0020
884 ERYTHEMA 400 0.0019
885 PULMONARY OEDEMA 87 0.0019
886 OROPHARYNGEAL PAIN 178 0.0019
887 INTERSTITIAL LUNG DISEASE 93 0.0019
888 DISEASE PROGRESSION 224 0.0019
889 ECZEMA 99 0.0019
890 BRADYCARDIA 100 0.0019
891 PNEUMONITIS 51 0.0019
892 BRONCHITIS 138 0.0019
893 HAEMORRHAGE 194 0.0019
894 BURNING SENSATION 130 0.0019
895 WHITE BLOOD CELL COUNT INCREASED 71 0.0018
896 CEREBROVASCULAR ACCIDENT 311 0.0018
897 ILLNESS 189 0.0018
898 URINARY RETENTION 61 0.0018
899 URINARY TRACT INFECTION 310 0.0018
900 THERAPEUTIC RESPONSE DECREASED 110 0.0018
901 NO ADVERSE EVENT 323 0.0018
902 DRUG ABUSE 148 0.0018
903 THROMBOSIS 143 0.0018
904 COLITIS 67 0.0018
905 STOMATITIS 107 0.0018
906 THERAPEUTIC RESPONSE UNEXPECTED 79 0.0018
907 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 125 0.0018
908 URTICARIA 294 0.0018
909 CHEST DISCOMFORT 179 0.0017
910 MUSCLE SPASMS 319 0.0017
911 HEAD INJURY 55 0.0017
912 IMPAIRED HEALING 57 0.0017
913 SWELLING 162 0.0017
914 DRUG ADMINISTRATION ERROR 53 0.0017
915 MYELOSUPPRESSION 62 0.0017
916 TREMOR 284 0.0017
917 MIGRAINE 163 0.0017
918 CARDIAC DISORDER 159 0.0017
919 LOWER RESPIRATORY TRACT INFECTION 77 0.0017
920 ALOPECIA 331 0.0017
921 FEELING ABNORMAL 403 0.0017
922 ATRIAL FIBRILLATION 163 0.0017
923 DYSGEUSIA 124 0.0017
924 HEART RATE INCREASED 163 0.0016
925 BLOOD PRESSURE DECREASED 108 0.0016
926 COVID-19 285 0.0016
927 PERIPHERAL SWELLING 250 0.0016
928 OCULAR HYPERAEMIA 77 0.0016
929 EYE SWELLING 60 0.0016
930 DEMENTIA 45 0.0016
931 SURGERY 93 0.0016
932 FEELING HOT 97 0.0016
933 EMOTIONAL DISORDER 48 0.0016
934 OESOPHAGEAL CARCINOMA 46 0.0015
935 RHEUMATOID ARTHRITIS 175 0.0015
936 DRY MOUTH 125 0.0015
937 VISION BLURRED 211 0.0015
938 VAGINAL HAEMORRHAGE 65 0.0015
939 CARDIAC FAILURE CONGESTIVE 120 0.0015
940 FALL 495 0.0015
941 EPISTAXIS 111 0.0015
942 PRODUCT SUBSTITUTION ISSUE 84 0.0015
943 TRANSIENT ISCHAEMIC ATTACK 49 0.0015
944 HAEMATOCHEZIA 80 0.0014
945 PSORIASIS 188 0.0014
946 BALANCE DISORDER 123 0.0014
947 RHINORRHOEA 90 0.0014
948 OXYGEN SATURATION DECREASED 77 0.0014
949 BLOOD GLUCOSE INCREASED 257 0.0014
950 CATARACT 81 0.0014
951 NERVOUSNESS 71 0.0014
952 NASAL CONGESTION 79 0.0013
953 SINUSITIS 136 0.0013
954 LIMB DISCOMFORT 41 0.0013
955 BLOOD PRESSURE INCREASED 202 0.0013
956 INFLUENZA 145 0.0013
957 COMPLETED SUICIDE 108 0.0013
958 WRONG TECHNIQUE IN DRUG USAGE PROCESS 47 0.0013
959 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 69 0.0013
960 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 251 0.0012
961 DYSPHONIA 72 0.0012
962 ACNE 92 0.0012
963 VISUAL IMPAIRMENT 150 0.0012
964 DRY EYE 59 0.0012
965 EYE PAIN 66 0.0012
966 THERAPEUTIC PRODUCT EFFECT DECREASED 51 0.0011
967 INCORRECT DOSE ADMINISTERED 257 0.0011
968 NASOPHARYNGITIS 204 0.0011
969 PLASMA CELL MYELOMA 43 0.0011
970 HOT FLUSH 83 0.0011
971 CONTUSION 106 0.0011
972 THROAT IRRITATION 49 0.0011
973 THERAPY INTERRUPTED 76 0.0011
974 DRY SKIN 138 0.0010
975 COLITIS ULCERATIVE 46 0.0010
976 RENAL CANCER 49 0.0010
977 FLUSHING 103 0.0010
978 BLOOD GLUCOSE DECREASED 47 0.0010
979 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 66 0.0009
980 ANAPHYLACTIC REACTION 51 0.0009
981 UNDERDOSE 64 0.0009
982 MALIGNANT NEOPLASM PROGRESSION 82 0.0008
983 DERMATITIS ATOPIC 42 0.0008
984 DRUG WITHDRAWAL SYNDROME 68 0.0008
985 EYE IRRITATION 43 0.0007
986 PRODUCT QUALITY ISSUE 97 0.0007
987 PROSTATE CANCER 55 0.0007
988 INJECTION SITE REACTION 46 0.0007
989 INJECTION SITE SWELLING 44 0.0006
990 INJECTION SITE PAIN 158 0.0005
991 DRUG DEPENDENCE 64 0.0004